We are live on
!
Find out more
WC
Weil Company Portfolio holdings
AUM
$445M
1-Year Est. Return
14.95%
This Fund
S&P 500
This Quarter
Est. Return
-1.62%
1 Year Est. Return
+14.95%
3 Year Est. Return
+51.9%
5 Year Est. Return
+85.1%
10 Year Est. Return
–
AUM
$199M
AUM Growth
-$15.4M
(-7.2%)
Cap. Flow
-$8.2M
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
41.56%
Holding
155
New
13
Increased
40
Reduced
43
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$2.42M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$1.95M |
| 3 |
BNY Mellon Concentrated International ETF
BKCI
|
+$1.88M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.83M |
| 5 |
Rockwell Automation
ROK
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.79M |
| 2 |
Houlihan Lokey
HLI
|
+$2.17M |
| 3 |
Hain Celestial
HAIN
|
+$1.65M |
| 4 |
Fortinet
FTNT
|
+$1.25M |
| 5 |
Gilead Sciences
GILD
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.98% |
| 2 | Real Estate | 16.95% |
| 3 | Financials | 13.22% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Xylem
XYL
$28.5B
| – | – |
-1,786
| Closed | -$214K |
|
|
DM
152
DELISTED
Desktop Metal, Inc.
DM
| – | – |
-1,500
| Closed | -$74K |
|
|
AKTS
153
DELISTED
Akoustis Technologies Inc
AKTS
| – | – |
-27,419
| Closed | -$183K |
|
|
PRTK
154
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| – | – |
-33,235
| Closed | -$149K |
|
|
GSKY
155
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| – | – |
-12,666
| Closed | -$144K |
|
Similar funds
RWM
BI
MLIC
JDLA
AFA
SGCM
WCP
ACA
Weil Company's Q1 2022 Portfolio in Review
As of Q1 2022, Weil Company held 155 positions worth $199M, down 7.2% from $214M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Weil Company withdrew a net $8.2M in Q1 2022, closing 31 positions and reducing 43 holdings. Its most notable exit was Gilead Sciences, an estimated $1.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 30% a quarter earlier, followed by Real Estate and Financials.
Against the trend, Weil Company opened a new position in BNY Mellon Concentrated International ETF worth $1.84M.
- Weil Company's largest Q1 2022 buy was BNY Mellon Concentrated International ETF: 39,750 shares worth $1.84M.
- Weil Company added most to United Therapeutics in Q1 2022, an estimated $2.42M increase.
- Weil Company's biggest Q1 2022 reduction was Apple, cutting an estimated $2.79M.
- Weil Company fully exited Gilead Sciences in Q1 2022, selling an estimated $1.2M.
- Weil Company's ten largest holdings make up 42% of its $199M portfolio in Q1 2022.
- Weil Company opened 13 new positions and closed 31 in Q1 2022.
- Weil Company's portfolio value fell 7.2% quarter-over-quarter to $199M.
Based on Weil Company's 13F filing for Q1 2022, filed 6 May 2022.